1 Friedman AJ, Rein MS, Harrison-Atlas D, et al. A randomized, placebo controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy. Fertil Steril 1989; 52:728-733.
2 Fedele L, Vercellini P, Bianchi S, et al. Treatment with GnRH agonists before myomectomy and the risk of short term myoma recurrence. Br J Obstet Gynaecol 1990; 97:393-396.
3 Shaw RW. Mechanism of LHRH analogue action in uterine fibroids. Horm Res 1989; 32 (Suppl 1):150-153.
4 Golan A, Bukovsky I, Pansky M, et al. Pre-operative gonadotrophin-releasing hormone agonist treatment in surgery for uterine leiomyomata. Hum Reprod 1993; 8:450-452.
5 Zullo F, Pellicano M, De Stefano R, et al. A prospective randomized study to evaluate leuprolide acetate treatment before laparoscopic myomectomy: efficacy and ultrasonographic predictors. Am J Obstet Gynecol 1998; 178:108-112.
6 Campo S, Garcea N. Laparoscopic myomectomy in premenopausal women with and without preoperative treatment using gonadotrophin-releasing hormone analogues. Hum Reprod 1999; 14:44-48.
7 Vercellini P, Trespidi L, Zaina B, et al. Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy: a controlled trial. Fertil Steril 2003; 79:1390-1395.
8 Lethaby A, Vollenhoven B, Sowter M. Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review. Br J Obstet Gynaecol 2002; 109:1097-1108.
9 Pritts EA. Fibroids and infertility: a systematic review of the evidence. Obstet Gynecol Surv 2001; 56:483-491.
10 Vercellini P, Maddalena S, DeGiorgi O, et al. Determinants of reproductive outcome after abdominal myomectomy for infertility. Fertil Steril 1999; 72:109-114.
11 Bozzini N, Rodrigues CJ, Petti DA, et al. Effects of treatment with gonadotropin releasing hormone agonist on the uterine leiomyomata structure. Acta Obstet Gynecol Scand 2003; 82:330-334.
12 Chegini N, Kornberg L. Gonadotropin releasing hormone analogue therapy alters signal transduction pathways involving mitogen-activated protein and focal adhesion kinases in leiomyoma. J Soc Gynecol Invest 2003; 10:21-26.
13 Chegini N, Ma C, Tang XM, Williams RS. Effects of GnRH analogues, 'add-back' steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-beta expression. Mol Hum Reprod 2002; 12:1071-1078.
14 Chegini N, Verala J, Luo X, et al. Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. J Soc Gynecol Invest 2003; 10:161-171.
15 De Leo V, la Marca A, Morgante G. Short-term treatment of uterine fibromyomas with danazol. Gynecol Obstet Invest 1999; 47:258-262.
16 La Marca A, Musacchio MC, Morgante G, et al. Hemodynamic effect of danazol therapy in women with uterine leiomyomata. Fertil Steril 2003; 79:1240-1242.
17 De Leo V, Morgante G, La Marca A, et al. A benefit-risk assessment of medical treatment for uterine leiomyomas. Drug Saf 2002; 25:759-779.
18o Eisinger SH, Meldrum S, Fiscella K, le Roux HD, Guzick DS. Low-dose mifepristone for uterine leiomyomata. Obstet Gynecol 2003; 101:243-250.
19 Palomba S, Sammartino A, Di Carlo C, et al. Effects of raloxifene treatment on uterine leiomyomas in postmenopausal women. Fertil Steril 2001; 76:38-43.
20 Palomba S, Orio F, Morelli M, et al. Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study. J Clin Endocrinol Metab 2002; 87:1502-1508.
21 Palomba S, Russo T, Orio F, et al. Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial. Hum Reprod 2002; 17:3213-3219.
22 Shozu M, Murakami K, Segawa T, et al. Successful treatment of a symptomatic uterine leiomyoma in a perimenopausal woman with a nonsteroidal aromatase inhibitor. Fertil Steril 2003; 79:628-631.
23 Grigorieva V, Chen-Mok M, Tarasova M, Mikhailov A. Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas. Fertil Steril 2003; 79:1194-1198.
24 Pinto I, Chimeno P, Romo A, et al. Uterine fibroids: uterine artery embolization versus abdominal hysterectomy for treatment: a prospective, randomized and controlled clinical trial. Radiology 2003; 226:425-431.
25 Pron G, Bennett J, Common A, et al. The Ontario fibroid embolization trial. Part 2. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids. Fertil Steril 2003; 79:120-127.
26 Ryu RK, Siddiqi A, Omary RA, et al. Sonography of delayed effects of uterine artery embolization on ovarian arterial perfusion and function. AJR Am J Roentgenol 2003; 181:89-92.
27o Tropeano G, Litwicka K, Di Stasi C, et al. Permanent amenorrhea associated with endometrial atrophy after uterine artery embolization for symptomatic uterine fibroids. Fertil Steril 2003; 79:132-135.
28 Payne JF, Haney AF. Serious complications of uterine artery embolization for conservative treatment of fibroids. Fertil Steril 2003; 79:128-131.
29 Colgan TJ, Pron G, Mocarski EJM, et al. Pathologic features of uteri and leiomyomas following uterine artery embolization for leiomyomas. Am J Surg Pathol 2003; 27:167-177.
30 Fogt F, Hinds N, Zimmerman RL. Histologic features of uterine leiomyomata treated with microsphere embolization. Obstet Gynecol 2003; 102:600-602.
31o Pelage J-P, Le Dref O, Beregi J-P, et al. Limited uterine artery embolization with tris-acryl gelatin microspheres for uterine fibroids. J Vasc Interv Radiol 2003; 14:15-20.
32o Zupi E, Pocek M, Dauri M, et al. Selective uterine artery embolization in the management of uterine myomas. Fertil Steril 2003; 79:107-111. This technique may become more popular for single fibroid patients.
33 Honda I, Sato T, Adachi H, et al. Uterine artery embolization for leiomyoma: complications and effects on fertility. Nippon Acta Radiologica 2003; 63:294-302.
34 Lefebvre G, Vilos G, Allaire C, et al. The management of uterine leiomyomas. J Obstet Gynaecol Can 2003; 25:396-418.
35 Goodwin SC. Uterine artery embolization for the treatment of uterine fibroids. Fertil Steril 2003; 79:136-137.